DYAI
DYAI
NASDAQ · Biotechnology

Dyadic International Inc

$0.68
-0.02 (-3.21%)
As of Mar 29, 10:53 PM ET ·
Financial Highlights (FY 2026)
Revenue
3.43M
Net Income
-5,705,101
Gross Margin
65.8%
Profit Margin
-166.2%
Rev Growth
+13.4%
D/E Ratio
2.01
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 65.8% 65.8% 60.3% 60.3%
Operating Margin -167.0% -150.3% -23.3% -23.1%
Profit Margin -166.2% -157.9% -25.2% -25.8%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 3.43M 3.03M 4.58M 5.07M
Gross Profit 2.26M 1.99M 2.76M 3.05M
Operating Income -5,733,892 -4,552,715 -1,067,325 -1,170,649
Net Income -5,705,101 -4,529,855 -1,151,647 -1,307,679
Gross Margin 65.8% 65.8% 60.3% 60.3%
Operating Margin -167.0% -150.3% -23.3% -23.1%
Profit Margin -166.2% -157.9% -25.2% -25.8%
Rev Growth +13.4% +13.4% +24.2% +16.9%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 8.48M 8.48M 10.08M 8.74M
Total Equity 4.21M 4.21M 17.40M 17.52M
D/E Ratio 2.01 2.01 0.58 0.50
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -5,713,740 -4,788,754 -1,556,423 -1,763,687
Free Cash Flow -1,101,967 -1,220,171